WallStSmart

Encompass Health Corp (EHC)vsInnovAge Holding Corp (INNV)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Encompass Health Corp generates 539% more annual revenue ($6.07B vs $949.17M). EHC leads profitability with a 10.0% profit margin vs -1.2%. EHC earns a higher WallStSmart Score of 75/100 (B+).

EHC

Strong Buy

75

out of 100

Grade: B+

Growth: 8.0Profit: 7.5Value: 6.7Quality: 6.0
Piotroski: 6/9Altman Z: 2.12

INNV

Avoid

24

out of 100

Grade: F

Growth: 5.3Profit: 2.5Value: 4.0Quality: 6.0
Piotroski: 5/9Altman Z: 1.74
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

EHCSignificantly Overvalued (-57.0%)

Margin of Safety

-57.0%

Fair Value

$72.26

Current Price

$104.01

$31.75 premium

UndervaluedFair: $72.26Overvalued
INNVSignificantly Overvalued (-25.5%)

Margin of Safety

-25.5%

Fair Value

$6.52

Current Price

$7.08

$0.56 premium

UndervaluedFair: $6.52Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

EHC4 strengths · Avg: 8.8/10
PEG RatioValuation
0.4110/10

Growing faster than its price suggests

Return on EquityProfitability
24.2%9/10

Every $100 of equity generates 24 in profit

P/E RatioValuation
17.4x8/10

Attractively priced relative to earnings

EPS GrowthGrowth
30.3%8/10

Earnings expanding 30.3% YoY

INNV1 strengths · Avg: 8.0/10
Revenue GrowthGrowth
15.5%8/10

15.5% revenue growth

Areas to Watch

EHC1 concerns · Avg: 3.0/10
Debt/EquityHealth
1.113/10

Elevated debt levels

INNV4 concerns · Avg: 2.8/10
Altman Z-ScoreHealth
1.744/10

Distress zone — elevated risk

Market CapQuality
$1.22B3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-9.7%2/10

ROE of -9.7% — below average capital efficiency

EPS GrowthGrowth
-87.8%2/10

Earnings declined 87.8%

Comparative Analysis Report

WallStSmart Research

Bull Case : EHC

The strongest argument for EHC centers on PEG Ratio, Return on Equity, P/E Ratio. PEG of 0.41 suggests the stock is reasonably priced for its growth.

Bull Case : INNV

The strongest argument for INNV centers on Revenue Growth. Revenue growth of 15.5% demonstrates continued momentum.

Bear Case : EHC

The primary concerns for EHC are Debt/Equity.

Bear Case : INNV

The primary concerns for INNV are Altman Z-Score, Market Cap, Return on Equity.

Key Dynamics to Monitor

EHC profiles as a value stock while INNV is a growth play — different risk/reward profiles.

EHC carries more volatility with a beta of 0.59 — expect wider price swings.

INNV is growing revenue faster at 15.5% — sustainability is the question.

EHC generates stronger free cash flow (151M), providing more financial flexibility.

Bottom Line

EHC scores higher overall (75/100 vs 24/100). Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Encompass Health Corp

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Encompass Health Corporation offers in-home and post-acute health care services in the United States. The company is headquartered in Birmingham, Alabama.

InnovAge Holding Corp

HEALTHCARE · MEDICAL CARE FACILITIES · USA

InnovAge Holding Corp. The company is headquartered in Denver, Colorado.

Visit Website →

Want to dig deeper into these stocks?